Roesti, E.S.; Boyle, C.N.; Zeman, D.T.; Sande-Melon, M.; Storni, F.; Cabral-Miranda, G.; Knuth, A.; Lutz, T.A.; Vogel, M.; Bachmann, M.F.
Vaccination Against Amyloidogenic Aggregates in Pancreatic Islets Prevents Development of Type 2 Diabetes Mellitus. Vaccines 2020, 8, 116.
https://doi.org/10.3390/vaccines8010116
AMA Style
Roesti ES, Boyle CN, Zeman DT, Sande-Melon M, Storni F, Cabral-Miranda G, Knuth A, Lutz TA, Vogel M, Bachmann MF.
Vaccination Against Amyloidogenic Aggregates in Pancreatic Islets Prevents Development of Type 2 Diabetes Mellitus. Vaccines. 2020; 8(1):116.
https://doi.org/10.3390/vaccines8010116
Chicago/Turabian Style
Roesti, Elisa S., Christina N. Boyle, Daniel T. Zeman, Marcos Sande-Melon, Federico Storni, Gustavo Cabral-Miranda, Alexander Knuth, Thomas A. Lutz, Monique Vogel, and Martin F. Bachmann.
2020. "Vaccination Against Amyloidogenic Aggregates in Pancreatic Islets Prevents Development of Type 2 Diabetes Mellitus" Vaccines 8, no. 1: 116.
https://doi.org/10.3390/vaccines8010116
APA Style
Roesti, E. S., Boyle, C. N., Zeman, D. T., Sande-Melon, M., Storni, F., Cabral-Miranda, G., Knuth, A., Lutz, T. A., Vogel, M., & Bachmann, M. F.
(2020). Vaccination Against Amyloidogenic Aggregates in Pancreatic Islets Prevents Development of Type 2 Diabetes Mellitus. Vaccines, 8(1), 116.
https://doi.org/10.3390/vaccines8010116